Debska-Vielhaber G - Search Results

1

Cytosolic, but not matrix, calcium is essential for adjustment of mitochondrial pyruvate supply.

Szibor M, Gizatullina Z, Gainutdinov T, Endres T, Debska-Vielhaber G, Kunz M, Karavasili N, Hallmann K, Schreiber F, Bamberger A, Schwarzer M, Doenst T, Heinze HJ, Lessmann V, Vielhaber S, Kunz WS, Gellerich FN. Szibor M, et al. Among authors: debska vielhaber g. J Biol Chem. 2020 Apr 3;295(14):4383-4397. doi: 10.1074/jbc.RA119.011902. Epub 2020 Feb 24. J Biol Chem. 2020. PMID: 32094224 Free PMC article.

2

The mechanism of neuroprotection by topiramate in an animal model of epilepsy.

Kudin AP, Debska-Vielhaber G, Vielhaber S, Elger CE, Kunz WS. Kudin AP, et al. Epilepsia. 2004 Dec;45(12):1478-87. doi: 10.1111/j.0013-9580.2004.13504.x. Epilepsia. 2004. PMID: 15571505 Free article.

3

Characterization of superoxide production sites in isolated rat brain and skeletal muscle mitochondria.

Kudin AP, Debska-Vielhaber G, Kunz WS. Kudin AP, et al. Biomed Pharmacother. 2005 May;59(4):163-8. doi: 10.1016/j.biopha.2005.03.012. Epub 2005 Mar 22. Biomed Pharmacother. 2005. PMID: 15862710

4

Brain 1H magnetic resonance spectroscopic differences in myotonic dystrophy type 2 and type 1.

Vielhaber S, Jakubiczka S, Gaul C, Schoenfeld MA, Debska-Vielhaber G, Zierz S, Heinze HJ, Niessen HG, Kaufmann J. Vielhaber S, et al. Muscle Nerve. 2006 Aug;34(2):145-52. doi: 10.1002/mus.20565. Muscle Nerve. 2006. PMID: 16642499

5

Metabolic progression markers of neurodegeneration in the transgenic G93A-SOD1 mouse model of amyotrophic lateral sclerosis.

Niessen HG, Debska-Vielhaber G, Sander K, Angenstein F, Ludolph AC, Hilfert L, Willker W, Leibfritz D, Heinze HJ, Kunz WS, Vielhaber S. Niessen HG, et al. Eur J Neurosci. 2007 Mar;25(6):1669-77. doi: 10.1111/j.1460-9568.2007.05415.x. Eur J Neurosci. 2007. PMID: 17432958

6

Subfield-specific loss of hippocampal N-acetyl aspartate in temporal lobe epilepsy.

Vielhaber S, Niessen HG, Debska-Vielhaber G, Kudin AP, Wellmer J, Kaufmann J, Schönfeld MA, Fendrich R, Willker W, Leibfritz D, Schramm J, Elger CE, Heinze HJ, Kunz WS. Vielhaber S, et al. Epilepsia. 2008 Jan;49(1):40-50. doi: 10.1111/j.1528-1167.2007.01280.x. Epub 2007 Sep 5. Epilepsia. 2008. PMID: 17822430 Free article.

7

Chapter 23 Quantification of superoxide production by mouse brain and skeletal muscle mitochondria.

Malinska D, Kudin AP, Debska-Vielhaber G, Vielhaber S, Kunz WS. Malinska D, et al. Methods Enzymol. 2009;456:419-37. doi: 10.1016/S0076-6879(08)04423-6. Methods Enzymol. 2009. PMID: 19348902

8

Genetic variation of the serotonin 2a receptor affects hippocampal novelty processing in humans.

Schott BH, Seidenbecher CI, Richter S, Wüstenberg T, Debska-Vielhaber G, Schubert H, Heinze HJ, Richardson-Klavehn A, Düzel E. Schott BH, et al. PLoS One. 2011 Jan 18;6(1):e15984. doi: 10.1371/journal.pone.0015984. PLoS One. 2011. PMID: 21267461 Free PMC article.

9

24-months results in two adults with Pompe disease on enzyme replacement therapy.

Vielhaber S, Brejova A, Debska-Vielhaber G, Kaufmann J, Feistner H, Schoenfeld MA, Awiszus F. Vielhaber S, et al. Clin Neurol Neurosurg. 2011 Jun;113(5):350-7. doi: 10.1016/j.clineuro.2010.09.016. Epub 2011 Apr 7. Clin Neurol Neurosurg. 2011. PMID: 21477922

10

Mitofusin 2 mutations affect mitochondrial function by mitochondrial DNA depletion.

Vielhaber S, Debska-Vielhaber G, Peeva V, Schoeler S, Kudin AP, Minin I, Schreiber S, Dengler R, Kollewe K, Zuschratter W, Kornblum C, Zsurka G, Kunz WS. Vielhaber S, et al. Acta Neuropathol. 2013 Feb;125(2):245-56. doi: 10.1007/s00401-012-1036-y. Epub 2012 Aug 28. Acta Neuropathol. 2013. PMID: 22926664

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page